510(k) Report

510(k) · Decided

Decided

Mammosite Multi Lumen

K092405510(k) SpecialDecided Aug 27, 200921-day reviewClass II21 CFR 892.5700

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Hologic, Inc. · JAQ System, Applicator, Radionuclide, Remote-Controlled

Cleared on Aug 27, 2009 as substantially equivalent to K041929 (Proxima Therapeutics, Inc., 2004) and 1 other predicate after a 21-day review. Its family tree reaches back 8 generations to 1986.

Decided
Aug 27, 2009
Review
21 days
Class
Class II
Product code
JAQ
Recalls
None
Predicates
2

Its longest line of descent runs back 8 generations to K864210 (1986). 23 ancestors in all, the oldest K853912 (1986). No later device cites it as a predicate yet.

  1. Root · 8 generations backK864210 Microselectron-HDR (High Dose Rate)Nucletron-Oldelft Corp. · 1986
  2. 7 generations backK953946 Microselectron-HDR Version 2Nucletron-Oldelft Corp. · 1996
  3. 6 generations backK020015 Implant Guidance System Applicator SetNucletron Corp. · 2002
  4. 5 generations backK032372 Nucletron Comfort Catheter System, Model 189.007Nucletron Corporation · 2003
  5. 4 generations backK061241 Biolucent Applicator, Model Rta-XXBiolucent, Inc. · 2006
  6. 3 generations backK070659 Biolucent Applicator KitBiolucent, Inc. · 2007
  7. 2 generations backK080565 Modification to: Savi Applicator KitCianna Medical, Inc. · 2008
  8. 1 generation backK081677 Savi Applicator KitCianna Medical, Inc. · 2008
  9. This deviceK092405 Mammosite Multi LumenHologic, Inc. · 2009
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K864210Microselectron-HDR (High Dose Rate)Nucletron-Oldelft Corp.1986—
−7K953946Microselectron-HDR Version 2Nucletron-Oldelft Corp.1996—
−6K020015Implant Guidance System Applicator SetNucletron Corp.2002—
−5K032372Nucletron Comfort Catheter System, Model 189.007Nucletron Corporation2003—
−4K061241Biolucent Applicator, Model Rta-XXBiolucent, Inc.2006—
−3K070659Biolucent Applicator KitBiolucent, Inc.2007—
−2K080565Modification to: Savi Applicator KitCianna Medical, Inc.2008—
−1K081677Savi Applicator KitCianna Medical, Inc.2008—
0 (this device)K092405Mammosite Multi LumenHologic, Inc.2009—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198610
198910
199110
199310
199610
199820
199920
200110
200210
200320
200410
200610
FIG. 1 — Lineage of K092405, 1986–2009Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JAQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JAQ device

  1. #1 K241853 Titanium Fletcher-Style Applicator Set Defined…score 14.9 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K041929Mammosite II Radiation Therapy System (RTS) Tray, Mammosite HDR Afterloader Accessories…
Summary page 1
…vices Name Manufacturer 510(k) Number MammoSite Radiation Hologic, Inc. K041929 Therapy System (RTS) SAVI Applicator Kit Cianna Medical K081677…
Proxima Therapeutics, Inc.2004—
*K081677Savi Applicator Kit
Summary page 1
…Radiation Hologic, Inc. K041929 Therapy System (RTS) SAVI Applicator Kit Cianna Medical K081677 The MammoSite ML is intended to provide brachytherapy when the physician Indications for chooses to deliver…
Cianna Medical, Inc.2008—

Also cleared against K041929: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 6 companies; a new generation was cleared every 1.4 years on median.
  • 3 of the 23 ancestors have a recall of any class.
  • 3 other devices also cite its predicate K041929.

How does its category compare?

All JAQ devices

JAQ System, Applicator, Radionuclide, Remote-Controlled: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · JAQ

6in 2025

2007: 112008: 102009: 102010: 22011: 22012: 72013: 62014: 72015: 112016: 62017: 72018: 72019: 22020: 42022: 12023: 22024: 102025: 62026 (partial year): 2
2007high 11 (2007) · low 0 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JAQ

91in 2025

2007: 48 days median2008: 34 days median2009: 27 days median2012: 89 days median2013: 100 days median2014: 116 days median2015: 183 days median2016: 154 days median2017: 229 days median2018: 252 days median2020: 62 days median2024: 126 days median2025: 91 days median
2007high 252 (2018) · low 27 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JAQ

1in 2019

2008: 52009: 12010: 22011: 132012: 52013: 12019: 12026 (partial year): 3
2007high 13 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JAQ

3in 2025

2007: 132008: 322009: 352010: 362011: 422012: 342013: 432014: 182015: 72016: 32017: 52018: 22019: 82020: 82021: 52022: 52023: 32024: 12025: 3
2007high 43 (2013) · low 1 (2024)2025

MAUDE reports naming product code JAQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071148013
20081034532
20091027135
20102—236
20112—1342
2012789534
20136100143
20147116018
20151118307
2016615403
2017722905
2018725202
20192—18
202046208
20210—05
20221—05
20232—03
20241012601
202569103
20262—3—

What is it indicated for?

The MammoSite ML is intended to provide brachytherapy when the physician chooses to deliver intracavitary radiation to the surgical margins following lumpectomy for breast cancer.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K092405: Mammosite Multi Lumen.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K092405

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026